Analyst Ratings for Tokai Pharmaceuticals (TKAI)

TKAI Rating Summary

  |   Expand Research on TKAI
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 4.3 / 10   Percentile Rank: 43%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/26/2016 Stifel N/A Downgrade Hold
(Buy)		 N/A
(N/A)		 5.20
(0.61)		 -88.27% Details
7/26/2016 BMO Capital
» Updated 8/23/2016		 N/A Downgrade Market Perform
(Outperform)		 1.15
(1.70)		 5.20
(0.61)		 -88.27% Details